# US 2021/0330892 A1 · Dose control system for injectable-drug delivery devices and associated methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330892 A1
- Document ID: US20210330892A1
- Status: Published application
- Kind: A1
- Application number: 16/479,782
- Filed: 2017-01-25
- Published: 2021-10-28
- Earliest claimed: 2017-01-25
- Assignees: Biocorp Production
- Applicants: Biocorp Production S.A.
- Inventors: Lionel ALDON; Alain MARCOZ
- Web page: https://patentgrep.com/patent/US20210330892A1

## CPC

- A61M 5/31533: {Dosing mechanisms, i.e. setting a dose (administrating mechanisms A61M5/31565)}
- A61M 5/31568: {Means keeping track of the total dose administered, e.g. since the cartridge was inserted}
- A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence)
- A61M 5/3155: {by rotational movement of dose setting member, e.g. during setting or filling of a syringe}
- A61M 5/31553: {without axial movement of dose setting member}
- G01B 7/30: for measuring angles or tapers; for testing the alignment of axes
- G01D 5/145: {influenced by the relative movement between the Hall device and magnetic fields (see G01R33/06)}
- G05B 13/041: {in which a variable is automatically adjusted to optimise the performance}
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- A61M 5/31525: {Dosing (burettes, pipettes B01L3/02)}
- A61M 2005/3126: {related to dosing}
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3368: Temperature
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/60: with identification means
- A61M 2205/6054: Magnetic identification systems
- G01D 18/004: {Continuous recalibration}
- G01D 18/008: {with calibration coefficients stored in memory}
- G01D 2205/22: by converting the rotary movement into a linear movement
- G01R 33/0017: {Means for compensating offset magnetic fields or the magnetic flux to be measured; Means for generating calibration magnetic fields}
- G01R 33/02: Measuring direction or magnitude of magnetic fields or magnetic flux (G01R33/20 takes precedence)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01B: MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
- G01D: MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G05B: CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS (systems for controlling or regulating non-electric variables G05D; systems for regulating electric or magnetic variables G05F; control devices or systems insofar as characterised by mechanical features only G05G)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

The invention relates to a dose control system configured for an injectable drug delivery device. The device comprises a disk-shaped diametral single-dipole magnet (9) attachable to a rotatable dose wheel, a housing removably attachable to the proximal extremity of the drug delivery body and comprising at least a first and a second magnetic field measurement means (8). An integrated control unit (2) is connected to the magnetic field measurement means and is configured to process information received therefrom. The magnetic field measurement means are located in the housing in a displaced axial relationship relative to the longitudinal axis of the drug delivery body and the magnet. The magnet is configured to co-rotate with the dose setting wheel and the integrated control unit is configured to provide a normalized vector with regard to the displaced axial relationship of the magnetic field measurement means, said normalized vector being derived from the measured magnetic field generated by the rotation of the magnet and measured by the magnetic field measurement means. A dose setting is calculated from said normalized vector.

## Claims

### Claim 1

A dose control system configured for an injectable drug delivery device, the drug delivery device comprising a substantially elongate drug delivery body, at least one injectable drug held by the body, the body having a distal and proximal extremity, and a rotatable dose setting wheel located at a proximal extremity of said drug delivery body, rotatable about a longitudinal axis of said drug delivery body, wherein the dose control system comprises:
a substantially disk-shaped diametral single-dipole magnet removably attachable, or permanently fixed, to the rotatable dose wheel at the proximal extremity of said drug delivery body;
a housing removably attachable to the proximal extremity of the drug delivery body, the removably attachable housing comprising:
at least a first and a second magnetic field measurement means configured to measure the magnetic field produced by the substantially disk-shaped diametral single-dipole magnet;
an integrated control unit connected to the at least first and second magnetic field measurement means configured to process information received from the at least first and second magnetic field measurement means;
wherein:
the at least first and second magnetic field measurement means are located in the removably attachable housing in a displaced axial relationship relative to the longitudinal axis of the drug delivery body and the substantially disk-shaped diametral single-dipole magnet;
the substantially disk-shaped diametral single-dipole magnet is configured to co-rotate with said dose setting wheel around the longitudinal axis of the drug delivery body; and
the integrated control unit is further configured to:
provide a normalized vector with regard to the displaced axial relationship of the magnetic field measurement means, said normalized vector being derived from the measured magnetic field generated by the rotation of the substantially disk-shaped diametral single-dipole magnet and measured by the magnetic field measurement means, and
calculate a dose setting from said normalized vector.

### Claim 2 (depends on 1)

The dose control system according to claim 1, wherein the integrated control unit is configured to calculate corrected offset values for said magnetic field measurement means.

### Claim 3 (depends on 1)

The dose control system according to claim 1, wherein the at least first and second magnetic field measurement means are located in the removably attachable housing adjacent to the proximal extremity of the drug delivery device body.

### Claim 4 (depends on 1)

The dose control system according to claim 1, wherein the at least first and second magnetic field measurement means are located distally from the proximal extremity within said housing.

### Claim 5 (depends on 1)

The dose control system according to claim 1, wherein the at least first and second magnetic field measurement means are located on a support structure located within the housing.

### Claim 6 (depends on 1)

The dose control system according to claim 1, wherein the first magnetic field measurement means and the second magnetic field detections are not in axial alignment with the substantially disk-shaped diametral single-dipole magnet.

### Claim 7 (depends on 1)

The dose control system according to claim 1, wherein the at least first and second magnetic field measurement means are magnetometers, and wherein the first magnetometer and the second magnetometer are configured to simultaneously and independently measure the magnetic field produced as the substantially disk-shaped diametral single-dipole magnet is rotated about the longitudinal axis of the drug delivery device body.

### Claim 8 (depends on 1)

The dose control system according to claim 1, wherein the at least first and second magnetic field measurement means are further configured to measure the magnetic field produced as the substantially disk-shaped diametral single-dipole magnet translates along the longitudinal axis of the drug delivery device body.

### Claim 9 (depends on 1)

The dose control system according to claim 1, wherein the integrated control unit is further configured to calculate offset values for said magnetic field measurement means via the formula:
[
x
offset
y
offset
z
offset
]
=
[
(
max
⁡
(
f
x
·
x
i
)
+
min
⁡
(
f
x
·
x
i
)
)
2
(
max
⁡
(
f
y
·
y
i
)
+
min
⁡
(
f
y
·
y
i
)
)
2
(
max
⁡
(
f
z
·
z
i
)
+
min
⁡
(
f
z
·
z
i
)
)
2
]
where x, y and z are the three orthogonal axes of magnetic field, and:
xi, yi, and zi are a series of points generated by corresponding vectors of the measured magnetic fields resembling a cloud of points in three dimensions, said cloud of points being sphericized by the factors:
[
x
i
y
i
z
i
]
=
[
f
x
·
x
i
f
y
·
y
i
f
Z
·
z
i
]

### Claim 10 (depends on 1)

The dose control system according to claim 1, wherein the integrated control unit is further configured to correct magnetic offset values via the formula:
[
x
corrected
y
corrected
z
corrected
]
=
[
f
x
·
x
i
-
x
offset
f
y
·
y
i
-
y
offset
f
z
·
z
i
-
z
offset
]

### Claim 11 (depends on 1)

The dose control system according to claim 1, wherein the integrated processing unit is further configured to correct magnetic field values measured by the magnetic field measurement means as a function of the non-axial alignment of the magnetic field measurement means relative to the substantially disk-shaped diametral single-dipole magnet.

### Claim 12 (depends on 1)

The dose control system according to claim 1, wherein the integrated processing unit is configured to correct magnetic field values measured by the magnetic field measurement means and resulting from a lack of axial alignment of the magnetic field measurement means with the substantially disk-shaped diametral single-dipole magnet by applying a rotation to a pseudo-vector representing a resultant pseudo-magnetic field comprised calculated from the measured magnetic fields of said first and second magnetic field measurement means, around one of three orthogonal axes x, y or z, to bring said pseudo-vector representing said resultant pseudo-magnetic field into a iso-normal projection plane.

### Claim 13 (depends on 1)

The dose control system according to claim 1, wherein the integrated processing unit is configured to correct magnetic field values measured by the magnetic field measurement means and resulting from a lack of axial alignment of said magnetic field measurement means with the substantially disk-shaped diametral single-dipole magnet, through application of the following calculations:
θ
x
=
a
⁢
⁢
tan
⁡
(
CR
z
CR
y
)
and
R
x
=
log
⁢
1
θ
x
+
c
2
-
c
1
c
3
*
c
4
+
c
5
where:
Rx is an angle expressed in degrees, enabling transformation of a measured magnetic field by rotation around an orthogonal axis, preferably the X axis, to reposition said magnetic field, expressed as an angular vector, such that said vector becomes substantially co-planar with its iso-normal projection plane; and
θx is the actual measured angle of rotation, in degrees, about the X axis;
c1=p1;
c2=Vadjust;
c3=p2−p1;
c4=p4−p3;
c5=p3
and:
Rx is modelled for values of θx for each distance d leading to a set of values di, θxi and Rxi, as follows:
R
x
=
log
⁢
1
θ
x
+
V
adjust
-
p
1
p
2
-
p
1
*
(
p
4
-
p
3
)
+
p
3
where
:
⁢
p
1
=
min
⁡
(
log
⁢
1
θ
xi
+
V
adjust
)
;
p
2
=
max
⁡
(
log
⁢
1
θ
xi
+
V
adjust
)
;
p
3
=
max
⁡
(
R
xi
-
θ
xi
)
;
p
4
=
min
⁡
(
R
xi
-
θ
xi
)
;
and
Vadjust is an adjustment variable for minimizing error between approximated values of Rx obtained via simulation and the values of Rx calculated by the system.

### Claim 14 (depends on 13)

The dose control system according to claim 13, wherein the integrated processing unit is configured to apply a low and high cut-off value to limit Rx values obtained during processing.

### Claim 15 (depends on 13)

The dose control system according to claim 13, wherein said low and high cut-off values are obtained via the functions min(θx) and max(θx) respectively, at the operating limits of the functioning system.

### Claim 16 (depends on 1)

The dose control system according to claim 1, wherein said system further comprises communication means configured to enable communication of information from the integrated control unit with a remote and/or local data processing system.

### Claim 17 (depends on 16)

The dose control system according to claim 16, wherein the remote and/or local data processing system comprises a smartphone application.

### Claim 18 (depends on 1)

The dose control system according to claim 1, wherein said dose control system further comprises a unique identifier that is communicated to a remote and/or local data processing system.

### Claim 19 (depends on 1)

The dose control system according to claim 1, wherein said dose control system further comprises temperature detection means.

### Claim 20 (depends on 1)

The dose control system according to claim 1, wherein said dose control system further comprises time determination means.

### Claim 21 (depends on 1)

The dose control system according to claim 1, wherein said dose control system further comprises autonomous power supply means.

### Claim 22 (depends on 1)

The dose control system according to claim 1, wherein said dose control system is configured to permit an unhindered or unchanged modus operandi of said drug delivery system when compared to an off the shelf injectable-drug delivery device.

### Claim 23 (depends on 1)

The dose control system according to claim 1, wherein the field strength of the magnet and the positioning of the magnetic field measurement means are configured in such a way that a difference of at least 100 microTesla (μT) is present between the values measured at the first magnetic field measurement means and the second magnetic field measurement means.

### Claim 24

Method A method for calculating a dose setting in a dose control system, said method comprising the steps of:
measuring a magnetic field (CM) produced by a rotatable substantially disk-shaped diametral single-dipole magnet with at least a first (m1) and a second (m2) magnetometer disposed in displaced axial alignment to an axis of rotation of said magnet;
calculating a resulting magnetic field pseudo-vector (CR);
optionally correcting said measured magnetic field CMm1 and CMm2;
calculating the angle of rotation to an iso-normal plane of projection for said magnetic field pseudo-vector;
transforming said magnetic field pseudo-vector with said angle of rotation to create, by rotation and projection, an iso-normal corrected magnetic field pseudo-vector (CR2);
calculating from said corrected iso-normal magnetic field pseudo-vector an angle of rotation of said magnet about said axis of rotation.

### Claim 25 (depends on 24)

The method according to claim 24, the method further comprising calculating a reference position of said magnet on a normal corresponding to a translated position of said magnet along said axis of rotation.
